本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

94.10
+0.60000.64%
盤後94.100.00000.00%18:06 EDT
成交量:49.00萬
成交額:4,608.47萬
市值:20.42億
市盈率:-81.57
高:95.60
開:93.60
低:93.23
收:93.50
52周最高:95.60
52周最低:52.50
股本:2,169.96萬
流通股本:1,696.65萬
量比:1.32
換手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):-1.1536
每股收益(LYR):-1.0429
淨資產收益率:-2.17%
總資產收益率:1.09%
市淨率:4.68
市盈率(LYR):-90.23

資料載入中...

2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/23

重要事件披露

Form 8-K - Current report